Literature DB >> 21724186

What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells.

Patricia Janicki1, Gerhard Schmidmaier.   

Abstract

Reconstruction of large bone defects or non-unions resulting from biochemical disorders, tumour resections or complicated fractures is still a challenge for orthopaedic and trauma surgery. On the one hand, autografts harbour most features of ideal bone graft substitutes but on the other hand, they have a lot insurmountable disadvantages. An ideal bone graft substitute should be biomechanically stable, able to degrade within an appropriate time frame, exhibit osteoconductive, osteogenic and osteoinductive properties and provide a favourable environment for invading blood vessels and bone forming cells. Whilst osteoconductivity of biomaterials for bone tissue engineering strategies can be directed by their composition, surface character and internal structure, osteoinductive and osteogenic features can be provided by growth factors originally participating in fracture healing and/or multipotent mesenchymal stromal/stem cells (MSC) capable of rebuilding bone and marrow structures. In this review, aspects of the clinical application of the most commonly used growth factors for bone repair, the bone morphogenetic proteins (BMPs), and the potential use of human MSC for clinical application will be discussed.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21724186     DOI: 10.1016/j.injury.2011.06.014

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  60 in total

1.  Mimicking the nanostructure of bone matrix to regenerate bone.

Authors:  Robert Kane; Peter X Ma1
Journal:  Mater Today (Kidlington)       Date:  2013-11-01       Impact factor: 31.041

2.  In vitro evaluation of bioactive strontium-based ceramic with rabbit adipose-derived stem cells for bone tissue regeneration.

Authors:  Beena Gopalan Mohan; Sivadasan Suresh Babu; Hari Krishna Varma; Annie John
Journal:  J Mater Sci Mater Med       Date:  2013-08-29       Impact factor: 3.896

3.  [Non-unions. From diagnosis to healing].

Authors:  E Steinhausen; M Glombitza; H-J Böhm; P-M Hax; D Rixen
Journal:  Unfallchirurg       Date:  2013-07       Impact factor: 1.000

4.  The effect of bone marrow concentrate and hyperbaric oxygen therapy on bone repair.

Authors:  J P Grassmann; J Schneppendahl; M Sager; A R Hakimi; M Herten; T T Loegters; M Wild; M Hakimi; J Windolf; P Jungbluth
Journal:  J Mater Sci Mater Med       Date:  2015-01-11       Impact factor: 3.896

5.  Synthesis and characterization of UPPE-PLGA-rhBMP2 scaffolds for bone regeneration.

Authors:  Zhichao Tian; Yuanli Zhu; Jinjun Qiu; Hanfeng Guan; Liangyu Li; Shouchao Zheng; Xuehai Dong; Jun Xiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11

6.  Mesenchymal stem cells with increased stromal cell-derived factor 1 expression enhanced fracture healing.

Authors:  Chih-Yuan Ho; Anita Sanghani; Jia Hua; Melanie Coathup; Priya Kalia; Gordon Blunn
Journal:  Tissue Eng Part A       Date:  2014-11-13       Impact factor: 3.845

7.  Dexamethasone-loaded hydroxyapatite enhances bone regeneration in rat calvarial defects.

Authors:  Reza Tavakoli-darestani; Alireza Manafi-rasi; Amin Kamrani-rad
Journal:  Mol Biol Rep       Date:  2013-11-27       Impact factor: 2.316

Review 8.  Adipose mesenchymal stem cells in the field of bone tissue engineering.

Authors:  Cecilia Romagnoli; Maria Luisa Brandi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 9.  Drug delivery using composite scaffolds in the context of bone tissue engineering.

Authors:  Cecilia Romagnoli; Federica D'Asta; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

10.  The Paracrine Role of Endothelial Cells in Bone Formation via CXCR4/SDF-1 Pathway.

Authors:  Tal Tamari; Rawan Kawar-Jaraisy; Ofri Doppelt; Ben Giladi; Nadin Sabbah; Hadar Zigdon-Giladi
Journal:  Cells       Date:  2020-05-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.